Michelle A.T. Hildebrandt

Author

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Hildebrandt, M, Hildebrandt, M. A., Hildebrandt, Michelle, a T, M A Hildebrandt, M A T Hildebrandt, M HILDEBRANDT, M. A. Hildebrandt, M. A. T. Hildebrandt, M. Hildebrandt, M.A. Hildebrandt

297

Publications

5.2K

Citations

H-Index

124

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Mayo Clinic The University of Texas Southwestern Medical Center Friedrich-Alexander-Universität Erlangen-Nürnberg The University of Texas Health Science Center at Houston

About

Michelle A.T. Hildebrandt is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	29	1.7K
2	Public Health	10	10	280
3	Health Sciences	4	4	87
4	Social Sciences	2	2	314
5	Biostatistics	1	1	39

Michelle A.T. Hildebrandt

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA) Patrick Hayden, Claire Roddie, Peter Bader, Annals of Oncology	2021	389
Different presurgical characteristics and seizure outcomes in children with focal cortical dysplasia type I or II Pavel Kršek, Tom Pieper, A. Karlmeier, Epilepsia	2008	229
Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma Michelle A.T. Hildebrandt, Jian Gu, Jun Lin, Oncogene UrologyCancer DevelopmentGenitourinary CancerMedicineEpigenetic Change	2010	204
Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer Xiaoan Liu, Qing H. Meng, Yuanqing Ye, Carcinogenesis Total BilirubinPrognostic EvaluationPrognostic BiomarkersBreast OncologyHepatology	2014	199
Increased Reelin Promoter Methylation Is Associated With Granule Cell Dispersion in Human Temporal Lobe Epilepsy Katja Kobow, Ina Jeske, Michelle A.T. Hildebrandt, Journal of Neuropathology & Experimental Neurology Reelin Promoter MethylationClinical NeuroscienceEpigeneticsSocial SciencesEpendyma	2009	177
Gemcitabine and Cytosine Arabinoside Cytotoxicity: Association with Lymphoblastoid Cell Expression Liang Li, Brooke L. Fridley, Krishna R. Kalari, Cancer Research	2008	175
Genetic Variations in the PI3K/PTEN/AKT/mTOR Pathway Are Associated With Clinical Outcomes in Esophageal Cancer Patients Treated With Chemoradiotherapy Michelle A.T. Hildebrandt, Hushan Yang, Mien‐Chie Hung, Journal of Clinical Oncology	2009	162
Towards a clinico-pathological classification of granule cell dispersion in human mesial temporal lobe epilepsies Ingmar Blümcke, Iris Kistner, Hans Clusmann, Acta Neuropathologica EpendymaNeurophysiologyNeuroanatomyMedicineNeuroscience	2009	137
Deficient memory acquisition in temporal lobe epilepsy is predicted by hippocampal granule cell loss E. Pauli, Michelle A.T. Hildebrandt, J. Romstöck, Neurology	2006	113
Neuropathological spectrum of cortical dysplasia in children with severe focal epilepsies Michelle A.T. Hildebrandt, Tom Pieper, Peter Winkler, Acta Neuropathologica Pediatric NeurosurgeryNeurological DisorderPediatricsSevere Focal EpilepsiesNeurology	2005	100

Page 1